Biotech

All Articles

2 cancer cells biotechs combine, producing global footprint

.OncoC4 is actually taking AcroImmune-- as well as its in-house scientific manufacturing capacities-...

Amgen reports initial period 3 gain for $400M chronic eczema medication

.Amgen has shared (PDF) the very first period 3 data on its own $400 million dermatitis drug, linkin...

Biogen, UCB file stage 3 lupus succeed after stopping working earlier trial

.Biogen as well as UCB's gamble on advancing right into period 3 on the back of a failed study hopes...

Aptadir wishes new RNA preventions can reverse tricky cancers

.Italian biotech Aptadir Rehabs has actually launched along with the guarantee that its pipeline of ...

Wave surfs DMD effectiveness to regulatory authorities' doors, sending stockpile

.Wave Life Sciences has actually satisfied its goal in a Duchenne muscular dystrophy (DMD) research,...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma fold, occup...

Achilles drips cell treatment system, bandages for cutbacks after overlooking 'business feasibility' goals

.Achilles Rehabs has destroyed its method. The British biotech is stopping work on its own clinical-...

Aligos heralds phase 2 MASH gain, reducing liver fat approximately 46%

.Aligos Rehabs is trumpeting a midstage succeed in metabolic-dysfunction affiliated steatohepatitis ...

Basilea scores $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work cultivating brand-new antifungals has obtained a substantial improveme...

Capricor offers Europe liberties to late-stage DMD therapy for $35M

.Possessing currently gathered up the USA liberties to Capricor Rehabs' late-stage Duchenne muscle d...